<DOC>
	<DOCNO>NCT02083692</DOCNO>
	<brief_summary>The purpose study assess effect metformin tumor metabolism patient head neck cancer evaluate metformin 's ability decrease TOMM20 expression squamous carcinoma cell decrease MCT4 expression fibroblast .</brief_summary>
	<brief_title>Pilot Study Metformin Head Neck Squamous Cell Cancer Its Effects Stromal-epithelial Metabolic Uncoupling</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosis head neck cancer biopsy proven , schedule appointment definitive resection tumor TJUH Age ≥ 18 year age ≤80 year old . Newly diagnose HNSCC cancer . No prior therapy HNSCC cancer permit enrollment trial . All subject must able comprehend sign write informed consent document . Pregnant may become pregnant metformin administration . On metformin reason precede 4 week . Diabetic patient eligible take metformin , insulin sulfonylurea . Received iodinated contrast dye le 48 hour prior screen meet temporary exclusion criterion receive metformin . These patient start investigational metformin 48 hour elapse contrast administration . Subjects schedule iodinated contrast dye administration within 48 hour definitive surgery exclude . Plasma alanine aminotransferase great 40 IU/dL . Plasma aspartate aminotransferase great 45 IU/dL . Plasma creatinine level great 1.3 mg/dL . Plasma alkaline phosphatase great 190 IU/dL . Plasma bicarbonate le 22 mEq/L history lactic metabolic acidosis . History congestive heart failure . Myocardial ischemia peripheral muscle ischemia . Sepsis severe infection . History lung disease currently require pharmacologic supplemental oxygen treatment . Scheduled definitive HNSCC cancer surgical resection less two week enrollment great five week enrollment . History hepatic dysfunction hepatic disease . Excessive alcohol intake define accordance CDC definitions 1 drink per day woman 2 drink per day men . All medication permit except contraindicate metformin current FDA recommendation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>